Results 251 to 260 of about 167,587 (340)
Cross‐Coupling Reactions in Aqueous Micellar Media
Thanks to their ability to efficiently and reliably construct carbon‐carbon and carbon‐heteroatom bonds, cross‐coupling reactions remain at the forefront of chemical research in both academic and industrial settings. However, the growing emphasis on sustainability has exposed the shortcomings of cross‐coupling chemistry in several areas, including the ...
Alexander Uner, Liam Thomas Ball
wiley +1 more source
Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage. [PDF]
Li YR+15 more
europepmc +1 more source
ABSTRACT Cancer is a result of uncontrolled cell growth with the potential to damage or spread to another part of the body. It is the deadliest disease in the world; therefore, rapid and sensitive detection is essential to fight it. In the past few decades, many diagnosis tools have been developed to detect cancer and monitor therapy progress.
Md Mobarok Karim, Tahera Lasker
wiley +1 more source
Optimizing Preclinical Models for Oral Cancer: The Influence of 4NQO Administration Routes on Tumor Development. [PDF]
Van den Bosch J+12 more
europepmc +1 more source
Chemically contaminated aquatic food resources and human cancer risk: retrospective [PDF]
Dawe, C. J.+7 more
core +1 more source
Abstract Quantitative risk assessments of chemicals are routinely performed using in vivo data from rodents; however, there is growing recognition that non‐animal approaches can be human‐relevant alternatives. There is an urgent need to build confidence in non‐animal alternatives given the international support to reduce the use of animals in toxicity ...
Marc A. Beal+14 more
wiley +1 more source
In reply to: "Letter to the editor in response to the article:'Squamous cell carcinoma arising in chronically damaged skin (Marjolijn's Ulcer)'". [PDF]
Miodovnik M+9 more
europepmc +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons+17 more
wiley +1 more source